Over the years, Unichem has invested significantly in its Research & Development (R&D) program to create state-of-the-art R&D facilities. Backed by a research team of over 150 highly-trained scientists with excellent credentials, the company’s R&D facilities are equipped with cutting-edge pharmaceutical research technology.

Unichem’s laboratories are equipped with the latest sophisticated analytical instruments like XRD, NMR, GC, LC MSMS, IR/UV, TGA, DSC, Prep HPLC and Flash Chromatography among others.

The company’s expanded R & D facilities have strengthened its Chemical and Formulation capabilities. At the same time, its new Biotechnology R&D facility, which focuses on cost-effective bio-similar products using recombinant micro organisms, is geared to provide a new edge to Unichem’s Research & Development efforts.


Unichem's R&D activities

Unichem’s R&D activities are focused on the following:

  • Novel cost-efficient Process Developments for Active Pharmaceutical Ingredients (APIs) and intermediates
  • Formulation Developments for generic APIs
  • Non-infringing routes for manufacturing products to be marketed internationally
  • Bio-similar products by recombinant DNA
  • Contract research to develop formulations for New Chemical Entities (NCEs) and Generic APIs

Inspired by an ambition to drive path-breaking innovative research, Unichem aims to enhance people’s health by consistently providing better, more effective and safer products.